MRI Contrast Agents Market Report

Global MRI Contrast Agents Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 08, 2022
  • PAGES：206
  • REPORT CODE：GMM852523
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • MRI Contrast Agents market report explains the definition, types, applications, major countries, and major players of the MRI Contrast Agents market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • BeiLu Pharma

    • Bayer

    • Bracco Imaging

    • Guerbet Group

    • YRPG

    • Lantheus

    • Hengrui Medicine

    By Type:

    • Extracellular Fluid Agents

    • Blood Pool Agents

    • Hepatobiliary (Liver) Agents

    By End-User:

    • Hospitals

    • Clinics

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global MRI Contrast Agents Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 MRI Contrast Agents Outlook to 2028- Original Forecasts

    • 2.2 MRI Contrast Agents Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term MRI Contrast Agents Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global MRI Contrast Agents Market- Recent Developments

    • 6.1 MRI Contrast Agents Market News and Developments

    • 6.2 MRI Contrast Agents Market Deals Landscape

    7 MRI Contrast Agents Raw Materials and Cost Structure Analysis

    • 7.1 MRI Contrast Agents Key Raw Materials

    • 7.2 MRI Contrast Agents Price Trend of Key Raw Materials

    • 7.3 MRI Contrast Agents Key Suppliers of Raw Materials

    • 7.4 MRI Contrast Agents Market Concentration Rate of Raw Materials

    • 7.5 MRI Contrast Agents Cost Structure Analysis

      • 7.5.1 MRI Contrast Agents Raw Materials Analysis

      • 7.5.2 MRI Contrast Agents Labor Cost Analysis

      • 7.5.3 MRI Contrast Agents Manufacturing Expenses Analysis

    8 Global MRI Contrast Agents Import and Export Analysis (Top 10 Countries)

    • 8.1 Global MRI Contrast Agents Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global MRI Contrast Agents Export by Region (Top 10 Countries) (2017-2028)

    9 Global MRI Contrast Agents Market Outlook by Types and Applications to 2022

    • 9.1 Global MRI Contrast Agents Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Extracellular Fluid Agents Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Blood Pool Agents Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Hepatobiliary (Liver) Agents Consumption and Growth Rate (2017-2022)

    • 9.2 Global MRI Contrast Agents Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise MRI Contrast Agents Market Analysis and Outlook till 2022

    • 10.1 Global MRI Contrast Agents Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States MRI Contrast Agents Consumption (2017-2022)

      • 10.2.2 Canada MRI Contrast Agents Consumption (2017-2022)

      • 10.2.3 Mexico MRI Contrast Agents Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany MRI Contrast Agents Consumption (2017-2022)

      • 10.3.2 UK MRI Contrast Agents Consumption (2017-2022)

      • 10.3.3 Spain MRI Contrast Agents Consumption (2017-2022)

      • 10.3.4 Belgium MRI Contrast Agents Consumption (2017-2022)

      • 10.3.5 France MRI Contrast Agents Consumption (2017-2022)

      • 10.3.6 Italy MRI Contrast Agents Consumption (2017-2022)

      • 10.3.7 Denmark MRI Contrast Agents Consumption (2017-2022)

      • 10.3.8 Finland MRI Contrast Agents Consumption (2017-2022)

      • 10.3.9 Norway MRI Contrast Agents Consumption (2017-2022)

      • 10.3.10 Sweden MRI Contrast Agents Consumption (2017-2022)

      • 10.3.11 Poland MRI Contrast Agents Consumption (2017-2022)

      • 10.3.12 Russia MRI Contrast Agents Consumption (2017-2022)

      • 10.3.13 Turkey MRI Contrast Agents Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China MRI Contrast Agents Consumption (2017-2022)

      • 10.4.2 Japan MRI Contrast Agents Consumption (2017-2022)

      • 10.4.3 India MRI Contrast Agents Consumption (2017-2022)

      • 10.4.4 South Korea MRI Contrast Agents Consumption (2017-2022)

      • 10.4.5 Pakistan MRI Contrast Agents Consumption (2017-2022)

      • 10.4.6 Bangladesh MRI Contrast Agents Consumption (2017-2022)

      • 10.4.7 Indonesia MRI Contrast Agents Consumption (2017-2022)

      • 10.4.8 Thailand MRI Contrast Agents Consumption (2017-2022)

      • 10.4.9 Singapore MRI Contrast Agents Consumption (2017-2022)

      • 10.4.10 Malaysia MRI Contrast Agents Consumption (2017-2022)

      • 10.4.11 Philippines MRI Contrast Agents Consumption (2017-2022)

      • 10.4.12 Vietnam MRI Contrast Agents Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil MRI Contrast Agents Consumption (2017-2022)

      • 10.5.2 Colombia MRI Contrast Agents Consumption (2017-2022)

      • 10.5.3 Chile MRI Contrast Agents Consumption (2017-2022)

      • 10.5.4 Argentina MRI Contrast Agents Consumption (2017-2022)

      • 10.5.5 Venezuela MRI Contrast Agents Consumption (2017-2022)

      • 10.5.6 Peru MRI Contrast Agents Consumption (2017-2022)

      • 10.5.7 Puerto Rico MRI Contrast Agents Consumption (2017-2022)

      • 10.5.8 Ecuador MRI Contrast Agents Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain MRI Contrast Agents Consumption (2017-2022)

      • 10.6.2 Kuwait MRI Contrast Agents Consumption (2017-2022)

      • 10.6.3 Oman MRI Contrast Agents Consumption (2017-2022)

      • 10.6.4 Qatar MRI Contrast Agents Consumption (2017-2022)

      • 10.6.5 Saudi Arabia MRI Contrast Agents Consumption (2017-2022)

      • 10.6.6 United Arab Emirates MRI Contrast Agents Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria MRI Contrast Agents Consumption (2017-2022)

      • 10.7.2 South Africa MRI Contrast Agents Consumption (2017-2022)

      • 10.7.3 Egypt MRI Contrast Agents Consumption (2017-2022)

      • 10.7.4 Algeria MRI Contrast Agents Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia MRI Contrast Agents Consumption (2017-2022)

      • 10.8.2 New Zealand MRI Contrast Agents Consumption (2017-2022)

    11 Global MRI Contrast Agents Competitive Analysis

    • 11.1 BeiLu Pharma

      • 11.1.1 BeiLu Pharma Company Details

      • 11.1.2 BeiLu Pharma MRI Contrast Agents Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 BeiLu Pharma MRI Contrast Agents Main Business and Markets Served

      • 11.1.4 BeiLu Pharma MRI Contrast Agents Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Bayer

      • 11.2.1 Bayer Company Details

      • 11.2.2 Bayer MRI Contrast Agents Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Bayer MRI Contrast Agents Main Business and Markets Served

      • 11.2.4 Bayer MRI Contrast Agents Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Bracco Imaging

      • 11.3.1 Bracco Imaging Company Details

      • 11.3.2 Bracco Imaging MRI Contrast Agents Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Bracco Imaging MRI Contrast Agents Main Business and Markets Served

      • 11.3.4 Bracco Imaging MRI Contrast Agents Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Guerbet Group

      • 11.4.1 Guerbet Group Company Details

      • 11.4.2 Guerbet Group MRI Contrast Agents Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Guerbet Group MRI Contrast Agents Main Business and Markets Served

      • 11.4.4 Guerbet Group MRI Contrast Agents Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 YRPG

      • 11.5.1 YRPG Company Details

      • 11.5.2 YRPG MRI Contrast Agents Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 YRPG MRI Contrast Agents Main Business and Markets Served

      • 11.5.4 YRPG MRI Contrast Agents Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Lantheus

      • 11.6.1 Lantheus Company Details

      • 11.6.2 Lantheus MRI Contrast Agents Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Lantheus MRI Contrast Agents Main Business and Markets Served

      • 11.6.4 Lantheus MRI Contrast Agents Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Hengrui Medicine

      • 11.7.1 Hengrui Medicine Company Details

      • 11.7.2 Hengrui Medicine MRI Contrast Agents Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Hengrui Medicine MRI Contrast Agents Main Business and Markets Served

      • 11.7.4 Hengrui Medicine MRI Contrast Agents Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    12 Global MRI Contrast Agents Market Outlook by Types and Applications to 2028

    • 12.1 Global MRI Contrast Agents Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Extracellular Fluid Agents Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Blood Pool Agents Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Hepatobiliary (Liver) Agents Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global MRI Contrast Agents Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise MRI Contrast Agents Market Analysis and Outlook to 2028

    • 13.1 Global MRI Contrast Agents Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States MRI Contrast Agents Consumption Forecast (2022-2028)

      • 13.2.2 Canada MRI Contrast Agents Consumption Forecast (2022-2028)

      • 13.2.3 Mexico MRI Contrast Agents Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany MRI Contrast Agents Consumption Forecast (2022-2028)

      • 13.3.2 UK MRI Contrast Agents Consumption Forecast (2022-2028)

      • 13.3.3 Spain MRI Contrast Agents Consumption Forecast (2022-2028)

      • 13.3.4 Belgium MRI Contrast Agents Consumption Forecast (2022-2028)

      • 13.3.5 France MRI Contrast Agents Consumption Forecast (2022-2028)

      • 13.3.6 Italy MRI Contrast Agents Consumption Forecast (2022-2028)

      • 13.3.7 Denmark MRI Contrast Agents Consumption Forecast (2022-2028)

      • 13.3.8 Finland MRI Contrast Agents Consumption Forecast (2022-2028)

      • 13.3.9 Norway MRI Contrast Agents Consumption Forecast (2022-2028)

      • 13.3.10 Sweden MRI Contrast Agents Consumption Forecast (2022-2028)

      • 13.3.11 Poland MRI Contrast Agents Consumption Forecast (2022-2028)

      • 13.3.12 Russia MRI Contrast Agents Consumption Forecast (2022-2028)

      • 13.3.13 Turkey MRI Contrast Agents Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China MRI Contrast Agents Consumption Forecast (2022-2028)

      • 13.4.2 Japan MRI Contrast Agents Consumption Forecast (2022-2028)

      • 13.4.3 India MRI Contrast Agents Consumption Forecast (2022-2028)

      • 13.4.4 South Korea MRI Contrast Agents Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan MRI Contrast Agents Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh MRI Contrast Agents Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia MRI Contrast Agents Consumption Forecast (2022-2028)

      • 13.4.8 Thailand MRI Contrast Agents Consumption Forecast (2022-2028)

      • 13.4.9 Singapore MRI Contrast Agents Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia MRI Contrast Agents Consumption Forecast (2022-2028)

      • 13.4.11 Philippines MRI Contrast Agents Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam MRI Contrast Agents Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil MRI Contrast Agents Consumption Forecast (2022-2028)

      • 13.5.2 Colombia MRI Contrast Agents Consumption Forecast (2022-2028)

      • 13.5.3 Chile MRI Contrast Agents Consumption Forecast (2022-2028)

      • 13.5.4 Argentina MRI Contrast Agents Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela MRI Contrast Agents Consumption Forecast (2022-2028)

      • 13.5.6 Peru MRI Contrast Agents Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico MRI Contrast Agents Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador MRI Contrast Agents Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain MRI Contrast Agents Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait MRI Contrast Agents Consumption Forecast (2022-2028)

      • 13.6.3 Oman MRI Contrast Agents Consumption Forecast (2022-2028)

      • 13.6.4 Qatar MRI Contrast Agents Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia MRI Contrast Agents Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates MRI Contrast Agents Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria MRI Contrast Agents Consumption Forecast (2022-2028)

      • 13.7.2 South Africa MRI Contrast Agents Consumption Forecast (2022-2028)

      • 13.7.3 Egypt MRI Contrast Agents Consumption Forecast (2022-2028)

      • 13.7.4 Algeria MRI Contrast Agents Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia MRI Contrast Agents Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand MRI Contrast Agents Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of MRI Contrast Agents

    • Figure of MRI Contrast Agents Picture

    • Table Global MRI Contrast Agents Import by Region (Top 10 Countries) (2017-2028)

    • Table Global MRI Contrast Agents Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Extracellular Fluid Agents Consumption and Growth Rate (2017-2022)

    • Figure Global Blood Pool Agents Consumption and Growth Rate (2017-2022)

    • Figure Global Hepatobiliary (Liver) Agents Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global MRI Contrast Agents Consumption by Country (2017-2022)

    • Table North America MRI Contrast Agents Consumption by Country (2017-2022)

    • Figure United States MRI Contrast Agents Consumption and Growth Rate (2017-2022)

    • Figure Canada MRI Contrast Agents Consumption and Growth Rate (2017-2022)

    • Figure Mexico MRI Contrast Agents Consumption and Growth Rate (2017-2022)

    • Table Europe MRI Contrast Agents Consumption by Country (2017-2022)

    • Figure Germany MRI Contrast Agents Consumption and Growth Rate (2017-2022)

    • Figure UK MRI Contrast Agents Consumption and Growth Rate (2017-2022)

    • Figure Spain MRI Contrast Agents Consumption and Growth Rate (2017-2022)

    • Figure Belgium MRI Contrast Agents Consumption and Growth Rate (2017-2022)

    • Figure France MRI Contrast Agents Consumption and Growth Rate (2017-2022)

    • Figure Italy MRI Contrast Agents Consumption and Growth Rate (2017-2022)

    • Figure Denmark MRI Contrast Agents Consumption and Growth Rate (2017-2022)

    • Figure Finland MRI Contrast Agents Consumption and Growth Rate (2017-2022)

    • Figure Norway MRI Contrast Agents Consumption and Growth Rate (2017-2022)

    • Figure Sweden MRI Contrast Agents Consumption and Growth Rate (2017-2022)

    • Figure Poland MRI Contrast Agents Consumption and Growth Rate (2017-2022)

    • Figure Russia MRI Contrast Agents Consumption and Growth Rate (2017-2022)

    • Figure Turkey MRI Contrast Agents Consumption and Growth Rate (2017-2022)

    • Table APAC MRI Contrast Agents Consumption by Country (2017-2022)

    • Figure China MRI Contrast Agents Consumption and Growth Rate (2017-2022)

    • Figure Japan MRI Contrast Agents Consumption and Growth Rate (2017-2022)

    • Figure India MRI Contrast Agents Consumption and Growth Rate (2017-2022)

    • Figure South Korea MRI Contrast Agents Consumption and Growth Rate (2017-2022)

    • Figure Pakistan MRI Contrast Agents Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh MRI Contrast Agents Consumption and Growth Rate (2017-2022)

    • Figure Indonesia MRI Contrast Agents Consumption and Growth Rate (2017-2022)

    • Figure Thailand MRI Contrast Agents Consumption and Growth Rate (2017-2022)

    • Figure Singapore MRI Contrast Agents Consumption and Growth Rate (2017-2022)

    • Figure Malaysia MRI Contrast Agents Consumption and Growth Rate (2017-2022)

    • Figure Philippines MRI Contrast Agents Consumption and Growth Rate (2017-2022)

    • Figure Vietnam MRI Contrast Agents Consumption and Growth Rate (2017-2022)

    • Table South America MRI Contrast Agents Consumption by Country (2017-2022)

    • Figure Brazil MRI Contrast Agents Consumption and Growth Rate (2017-2022)

    • Figure Colombia MRI Contrast Agents Consumption and Growth Rate (2017-2022)

    • Figure Chile MRI Contrast Agents Consumption and Growth Rate (2017-2022)

    • Figure Argentina MRI Contrast Agents Consumption and Growth Rate (2017-2022)

    • Figure Venezuela MRI Contrast Agents Consumption and Growth Rate (2017-2022)

    • Figure Peru MRI Contrast Agents Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico MRI Contrast Agents Consumption and Growth Rate (2017-2022)

    • Figure Ecuador MRI Contrast Agents Consumption and Growth Rate (2017-2022)

    • Table GCC MRI Contrast Agents Consumption by Country (2017-2022)

    • Figure Bahrain MRI Contrast Agents Consumption and Growth Rate (2017-2022)

    • Figure Kuwait MRI Contrast Agents Consumption and Growth Rate (2017-2022)

    • Figure Oman MRI Contrast Agents Consumption and Growth Rate (2017-2022)

    • Figure Qatar MRI Contrast Agents Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia MRI Contrast Agents Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates MRI Contrast Agents Consumption and Growth Rate (2017-2022)

    • Table Africa MRI Contrast Agents Consumption by Country (2017-2022)

    • Figure Nigeria MRI Contrast Agents Consumption and Growth Rate (2017-2022)

    • Figure South Africa MRI Contrast Agents Consumption and Growth Rate (2017-2022)

    • Figure Egypt MRI Contrast Agents Consumption and Growth Rate (2017-2022)

    • Figure Algeria MRI Contrast Agents Consumption and Growth Rate (2017-2022)

    • Table Oceania MRI Contrast Agents Consumption by Country (2017-2022)

    • Figure Australia MRI Contrast Agents Consumption and Growth Rate (2017-2022)

    • Figure New Zealand MRI Contrast Agents Consumption and Growth Rate (2017-2022)

    • Table BeiLu Pharma Company Details

    • Table BeiLu Pharma MRI Contrast Agents Sales, Price, Value and Gross Profit (2017-2022)

    • Table BeiLu Pharma MRI Contrast Agents Main Business and Markets Served

    • Table BeiLu Pharma MRI Contrast Agents Product Portfolio

    • Table Bayer Company Details

    • Table Bayer MRI Contrast Agents Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer MRI Contrast Agents Main Business and Markets Served

    • Table Bayer MRI Contrast Agents Product Portfolio

    • Table Bracco Imaging Company Details

    • Table Bracco Imaging MRI Contrast Agents Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bracco Imaging MRI Contrast Agents Main Business and Markets Served

    • Table Bracco Imaging MRI Contrast Agents Product Portfolio

    • Table Guerbet Group Company Details

    • Table Guerbet Group MRI Contrast Agents Sales, Price, Value and Gross Profit (2017-2022)

    • Table Guerbet Group MRI Contrast Agents Main Business and Markets Served

    • Table Guerbet Group MRI Contrast Agents Product Portfolio

    • Table YRPG Company Details

    • Table YRPG MRI Contrast Agents Sales, Price, Value and Gross Profit (2017-2022)

    • Table YRPG MRI Contrast Agents Main Business and Markets Served

    • Table YRPG MRI Contrast Agents Product Portfolio

    • Table Lantheus Company Details

    • Table Lantheus MRI Contrast Agents Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lantheus MRI Contrast Agents Main Business and Markets Served

    • Table Lantheus MRI Contrast Agents Product Portfolio

    • Table Hengrui Medicine Company Details

    • Table Hengrui Medicine MRI Contrast Agents Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hengrui Medicine MRI Contrast Agents Main Business and Markets Served

    • Table Hengrui Medicine MRI Contrast Agents Product Portfolio

    • Figure Global Extracellular Fluid Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Blood Pool Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hepatobiliary (Liver) Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global MRI Contrast Agents Consumption Forecast by Country (2022-2028)

    • Table North America MRI Contrast Agents Consumption Forecast by Country (2022-2028)

    • Figure United States MRI Contrast Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada MRI Contrast Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico MRI Contrast Agents Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe MRI Contrast Agents Consumption Forecast by Country (2022-2028)

    • Figure Germany MRI Contrast Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK MRI Contrast Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain MRI Contrast Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium MRI Contrast Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure France MRI Contrast Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy MRI Contrast Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark MRI Contrast Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland MRI Contrast Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway MRI Contrast Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden MRI Contrast Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland MRI Contrast Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia MRI Contrast Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey MRI Contrast Agents Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC MRI Contrast Agents Consumption Forecast by Country (2022-2028)

    • Figure China MRI Contrast Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan MRI Contrast Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure India MRI Contrast Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea MRI Contrast Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan MRI Contrast Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh MRI Contrast Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia MRI Contrast Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand MRI Contrast Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore MRI Contrast Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia MRI Contrast Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines MRI Contrast Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam MRI Contrast Agents Consumption Forecast and Growth Rate (2022-2028)

    • Table South America MRI Contrast Agents Consumption Forecast by Country (2022-2028)

    • Figure Brazil MRI Contrast Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia MRI Contrast Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile MRI Contrast Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina MRI Contrast Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela MRI Contrast Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru MRI Contrast Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico MRI Contrast Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador MRI Contrast Agents Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC MRI Contrast Agents Consumption Forecast by Country (2022-2028)

    • Figure Bahrain MRI Contrast Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait MRI Contrast Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman MRI Contrast Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar MRI Contrast Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia MRI Contrast Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates MRI Contrast Agents Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa MRI Contrast Agents Consumption Forecast by Country (2022-2028)

    • Figure Nigeria MRI Contrast Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa MRI Contrast Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt MRI Contrast Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria MRI Contrast Agents Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania MRI Contrast Agents Consumption Forecast by Country (2022-2028)

    • Figure Australia MRI Contrast Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand MRI Contrast Agents Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US